Related Experiment Video

Updated: Jun 21, 2026

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
09:00

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke

Published on: February 10, 2023

Choosing the ideal drug for hypertension after ischemic stroke

Eduard Rozner1, Arnold Eggers, Daniel Rosenbaum

  • 1SUNY Downstate Medical Center, Department of Neurology, 450 Clarkson Avenue, Box 1213, Brooklyn, NY 11203, USA.

Current Hypertension Reports
|July 16, 2009
PubMed

Insights

Controlling high blood pressure is key to stroke prevention. Amlodipine, a calcium-channel blocker, consistently proves effective, often superior to other hypertension medications in reducing stroke risk.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Hypertension control is crucial for preventing stroke.
  • Debate exists regarding the most effective antihypertensive medication classes for secondary stroke prevention.
  • Comparing medication efficacy is challenging due to variations in achieved blood pressure and drug combinations.

Purpose of the Study:

  • To review studies assessing the efficacy of different antihypertensive agent classes in secondary stroke prevention.
  • To analyze the comparative effectiveness of various hypertension medications.
  • To evaluate the role of achieved blood pressure versus drug-specific effects in stroke risk reduction.

Main Methods:

  • Review of studies on antihypertensive agents for secondary stroke prevention.
  • Meta-analysis and meta-regression modeling to predict risk reduction based on achieved blood pressure.
  • Comparison of amlodipine (a calcium-channel blocker) against other agents.

Main Results:

  • The reduction in blood pressure is the primary factor in decreasing stroke risk.
  • Amlodipine has consistently demonstrated equal or superior efficacy compared to other agents.
  • The "blood pressure-independent" effects of medications are questioned in meta-regression analyses.

Conclusions:

  • Lowering blood pressure remains the most significant factor in secondary stroke prevention.
  • Amlodipine is a highly effective calcium-channel blocker for hypertension management and stroke risk reduction.
  • Further research may be needed to fully elucidate the blood pressure-independent effects of antihypertensive agents.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...